还有新冠吗_老虎社区_美港股上老虎 - 老虎社区

还有新冠吗

FDA批准了诺瓦瓦克斯医药的COVID-19疫苗

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

Garin_9101
05-19
Garin_9101
有，长新冠了，香港媒体有报道
澄子930
05-19
澄子930
有，很严重

发表看法

2

2

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":436752882757848,"tweetId":"436752882757848","gmtCreate":1747642175587,"gmtModify":1747642177331,"author":{"id":3440671289079356,"idStr":"3440671289079356","authorId":3440671289079356,"authorIdStr":"3440671289079356","name":"小马化腾","avatar":"https://static.tigerbbs.com/e5f0a13b13ee40c1b5b3af1227cf381b","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":13,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>还有新冠吗</p></body></html>","htmlText":"<html><head></head><body><p>还有新冠吗</p></body></html>","text":"还有新冠吗","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/436752882757848","repostId":1159443350,"repostType":4,"repost":{"id":"1159443350","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1747641858,"share":"https://www.laohu8.com/m/news/1159443350?lang=&edition=full","pubTime":"2025-05-19 16:04","market":"us","language":"zh","title":"FDA批准了诺瓦瓦克斯医药的COVID-19疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1159443350","media":"老虎资讯综合","summary":"但仅限于特定人群使用。","content":"<html><head></head><body><p>5月19日周一，诺瓦瓦克斯医药盘前大涨超18%。根据报道，FDA批准了诺瓦瓦克斯的COVID-19疫苗Nuvaxovid，但仅限于特定人群使用。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/28a18d643fd1f92c648ab32bab5332f8\" tg-width=\"450\" tg-height=\"129\"/></p><p>获准使用的对象包括65岁及以上的老年人，以及12至64岁之间至少患有一种可能增加COVID-19重症风险的潜在疾病的人群。尽管批准范围有限，但这一决定仍被视为公司的重要里程碑。诺瓦瓦克斯首席执行官约翰·雅各布斯表示，这一批准为人们获得疫苗铺平了道路。</p><p style=\"text-align: start;\">值得注意的是，这项批准来之不易。诺瓦瓦克斯首席企业事务与宣传官西尔维亚·泰勒透露，公司在与监管机构进行了大量来回沟通后，于上周五深夜才收到批准通知。此前，FDA曾多次推迟批准决定。尽管批准范围有限，但泰勒表示公司并不担心，因为获批人群与一般寻求接种疫苗的人群相符。这一批准可能为诺瓦瓦克斯开辟新的市场机会，尤其是在针对高风险群体的疫苗接种方面，这也解释了投资者的积极反应和随之而来的股价大幅上涨。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA批准了诺瓦瓦克斯医药的COVID-19疫苗</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA批准了诺瓦瓦克斯医药的COVID-19疫苗\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2025-05-19 16:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>5月19日周一，诺瓦瓦克斯医药盘前大涨超18%。根据报道，FDA批准了诺瓦瓦克斯的COVID-19疫苗Nuvaxovid，但仅限于特定人群使用。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/28a18d643fd1f92c648ab32bab5332f8\" tg-width=\"450\" tg-height=\"129\"/></p><p>获准使用的对象包括65岁及以上的老年人，以及12至64岁之间至少患有一种可能增加COVID-19重症风险的潜在疾病的人群。尽管批准范围有限，但这一决定仍被视为公司的重要里程碑。诺瓦瓦克斯首席执行官约翰·雅各布斯表示，这一批准为人们获得疫苗铺平了道路。</p><p style=\"text-align: start;\">值得注意的是，这项批准来之不易。诺瓦瓦克斯首席企业事务与宣传官西尔维亚·泰勒透露，公司在与监管机构进行了大量来回沟通后，于上周五深夜才收到批准通知。此前，FDA曾多次推迟批准决定。尽管批准范围有限，但泰勒表示公司并不担心，因为获批人群与一般寻求接种疫苗的人群相符。这一批准可能为诺瓦瓦克斯开辟新的市场机会，尤其是在针对高风险群体的疫苗接种方面，这也解释了投资者的积极反应和随之而来的股价大幅上涨。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/9d8c867c1ef8b5c5f7cc9a1a0968e031","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159443350","content_text":"5月19日周一，诺瓦瓦克斯医药盘前大涨超18%。根据报道，FDA批准了诺瓦瓦克斯的COVID-19疫苗Nuvaxovid，但仅限于特定人群使用。获准使用的对象包括65岁及以上的老年人，以及12至64岁之间至少患有一种可能增加COVID-19重症风险的潜在疾病的人群。尽管批准范围有限，但这一决定仍被视为公司的重要里程碑。诺瓦瓦克斯首席执行官约翰·雅各布斯表示，这一批准为人们获得疫苗铺平了道路。值得注意的是，这项批准来之不易。诺瓦瓦克斯首席企业事务与宣传官西尔维亚·泰勒透露，公司在与监管机构进行了大量来回沟通后，于上周五深夜才收到批准通知。此前，FDA曾多次推迟批准决定。尽管批准范围有限，但泰勒表示公司并不担心，因为获批人群与一般寻求接种疫苗的人群相符。这一批准可能为诺瓦瓦克斯开辟新的市场机会，尤其是在针对高风险群体的疫苗接种方面，这也解释了投资者的积极反应和随之而来的股价大幅上涨。","news_type":1,"symbols_score_info":{"NVAX":1.1}},"isVote":1,"tweetType":1,"viewCount":648,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":10,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":436841425518648,"commentId":"436841425518648","gmtCreate":1747663409171,"gmtModify":1747668095164,"authorId":3585267913435974,"author":{"id":3585267913435974,"idStr":"3585267913435974","authorId":3585267913435974,"name":"Garin_9101","avatar":"https://static.tigerbbs.com/a80d9a997ce6bc6784ec42f2c0322114","vip":1,"currentWearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.07.07","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":436752882757848,"objectIdStr":"436752882757848","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"有，长新冠了，香港媒体有报道","text":"有，长新冠了，香港媒体有报道","html":"有，长新冠了，香港媒体有报道","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":436846153580576,"commentId":"436846153580576","gmtCreate":1747665000456,"gmtModify":1747668095903,"authorId":4205966696217252,"author":{"id":4205966696217252,"idStr":"4205966696217252","authorId":4205966696217252,"name":"澄子930","avatar":"https://static.tigerbbs.com/eaaa7e22ff8ed6dd03861094c9174176","vip":1,"currentWearingBadge":{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.05.06","exceedPercentage":"80.77%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":8,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":436752882757848,"objectIdStr":"436752882757848","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"有，很严重","text":"有，很严重","html":"有，很严重","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/436752882757848"}